மருந்து ப்ரொட்யூஸர்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ப்ரொட்யூஸர்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ப்ரொட்யூஸர்ஸ் Today - Breaking & Trending Today

OPPI along with health associations announce campaign to support govt initiatives on COVID-19

OPPI along with health associations announce campaign to support govt initiatives on COVID-19
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Healthcare Federation Of India , Searpharm Foruma Forum , International Alliance , Organisation Of Pharmaceutical Producers India , Indian Pharmaceutical Association , Pharmaceutical Producers , International Alliance Of Patient Organizations , Healthcare Federation , National Pharmaceutical Association , South East Asian Region , சுகாதாரம் கூட்டமைப்பு ஆஃப் இந்தியா , சர்வதேச கூட்டணி , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா , இந்தியன் மருந்து சங்கம் , மருந்து ப்ரொட்யூஸர்ஸ் , சர்வதேச கூட்டணி ஆஃப் நோயாளி ஆர்கநைஸேஶந்ஸ் , சுகாதாரம் கூட்டமைப்பு , தேசிய மருந்து சங்கம் , தெற்கு கிழக்கு ஆசிய பகுதி ,

Focused COVID-19 Media Monitoring, Nepal (May 20, 2021) - Nepal

Focused COVID-19 Media Monitoring, Nepal (May 20, 2021)
Format
EMERGING THEME(S)
Epidemiology and Disease Control Division says new COVID-19 variant B.1.617.2 is 50 per cent more infectious than previous variants; it is aggressive and deadly, warns Director of Sukraraj Tropical and Infectious Disease Hospital
Nepal reports 8,064 new COVID-19 infections, 246 deaths on May 19; infection in Nepal reported as being highest in age group of 20-39 years, those in 30-39 group most affected
Government finally starts procurement process of COVID-19 vaccines from India and Russia, has not initiated it with China as Department of Drug Administration does not have address of Chinese company to send the correspondence to; Serum Institute of India will start exporting its COVID-19 vaccine only by the yearend ....

Bhagwan Koirala , Crisis Management Center , Department Of Drug Administration , Disease Control Division , Association Of Pharmaceutical Producers Nepal , China As Department Of Drug Administration , Serum Institute Of India , Sukraraj Tropical , Infectious Disease , Drug Administration , Serum Institute , Management Center , Bir Hospital , Pharmaceutical Producers , பகவான் கொய்ராலா , நெருக்கடி மேலாண்மை மையம் , நோய் கட்டுப்பாடு பிரிவு , சங்கம் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் நேபால் , சீரம் நிறுவனம் ஆஃப் இந்தியா , தொற்று நோய் , சீரம் நிறுவனம் , மேலாண்மை மையம் , பிர் மருத்துவமனை , மருந்து ப்ரொட்யூஸர்ஸ் ,

OPPI warns against vaccine patent waiver

OPPI warns against vaccine patent waiver
Top Searches
OPPI warns against vaccine patent waiver
TNN / Updated: May 12, 2021, 06:19 IST
FacebookTwitterLinkedinEMail
Representative image
MUMBAI: Waiving of intellectual property (IP) rights will neither lead to higher production of vaccines or their increased deployment to fight Covid, since that is not the barrier to ensure availability of vaccines in India, according to the Organisation of Pharmaceutical Producers (OPPI), a body representing pharma MNCs. It warned that a waiver of patents could impact patient safety by opening doors for counterfeit vaccines to enter the supply chain.
The statement follows a drastic turnaround of the US recently supporting a waiver of IP on Covid vaccines. India and South Africa are engaged jointly at the World Trade Organization for a patient waiver submitted in October last year for all Covid medical tools. Recently, faced with crucial vaccines shortages and key Covid d ....

South Africa , Organisation Of Pharmaceutical Producers , World Trade Organization , Pharmaceutical Producers , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் , உலகம் வர்த்தகம் ஆர்கநைஸேஶந் , மருந்து ப்ரொட்யூஸர்ஸ் ,

IP waiver proposal may open door to counterfeits: OPPI - The Hindu BusinessLine

As a global proposal from India and South Africa to waive intellectual property (IP) on Covid-19-linked health technologies garners support, the Organisation of Pharmaceutical Producers of India (OPPI) has countered that such a move “will neither lead to increased production of vaccines nor increased deployment”. Instead, they caution, it could open the door for counterfeit vaccines.
OPPI’s response comes days after the US put its might behind the IP waiver for vaccines during the pandemic period, a move that is expected to swing the support of other countries that may have earlier opposed the proposal at the WTO. ....

South Africa , Organisation Of Pharmaceutical Producers India , Serum Institute Of India , Pharmaceutical Producers , Serum Institute , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா , சீரம் நிறுவனம் ஆஃப் இந்தியா , மருந்து ப்ரொட்யூஸர்ஸ் , சீரம் நிறுவனம் ,

Фармацевты предупреждают о дефиците лекарств в России

Фармацевты предупреждают о дефиците лекарств в России
ura.news - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ura.news Daily Mail and Mail on Sunday newspapers.

International Atomic Energy Agency , Territory Of The Eurasian Economic Union , Pharmaceutical Producers , Eurasian Economic Union , Producers Are , All Russian , Also Subscribe , Google News , Director General , Japan Will Help , மருந்து ப்ரொட்யூஸர்ஸ் , யூரேசியன் பொருளாதார தொழிற்சங்கம் , அனைத்தும் ரஷ்ய , மேலும் பதிவு , கூகிள் செய்தி , இயக்குனர் ஜநரல் ,